Rao, Nanyan <br/><br/>
Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy.  [electronic resource] 

 -  Chemotherapy  2017 
 - 246-255 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1421-9794 
<br/><br/><label>Standard No.: </label>10.1159/000470900  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anthracyclines--therapeutic use<br/>Antigens, Neoplasm--metabolism<br/>Antineoplastic Agents--therapeutic use<br/>Bridged-Ring Compounds--therapeutic use<br/>CD4-Positive T-Lymphocytes--cytology<br/>CD8-Positive T-Lymphocytes--cytology<br/>DNA Topoisomerases, Type II--metabolism<br/>DNA-Binding Proteins--metabolism<br/>Disease-Free Survival<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Ki-67 Antigen--metabolism<br/>Linear Models<br/>Lymphocytes, Tumor-Infiltrating--cytology<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Remission Induction<br/>Survival Rate<br/>Taxoids--therapeutic use<br/>Triple Negative Breast Neoplasms--drug therapy<br/>Tumor Suppressor Protein p53--metabolism